Tech Company Financing Transactions
Step Pharma Funding Round
Step Pharma, based in Saint-Genis-Pouilly, secured $3 million in funding from European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
2/19/2026
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the clinical development of its lead candidate, dencatistat, specifically for CTPS2 null ovarian and endometrial cancers, including expanding Phase 1b trials and preparing for Phase 2 studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 rue Louis et Auguste Lumière, Technoparc du Pays-de-Gex
Saint-Genis-Pouilly, 01630
France
Saint-Genis-Pouilly, 01630
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Step Pharma is the world leader in CTPS1 inhibition. Step Pharma is pioneering a novel class of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). Step Pharma is led by a highly motivated management team and an exceptional syndicate of international investors, all driven to bring about a step change in cancer treatment for patients.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 2/19/2026: Orion Properties venture capital transaction
Next: 2/19/2026: Code Metal venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








